Phanes Biotech is an early-stage drug development biotechnology company focused on developing molecules to prevent, inhibit, and reverse neurodegenerative diseases and developmental disabilities by neural regeneration, and in the case of tauopathies by tau immunotherapy.
Company Details
- Employees
- 4
- Founded
- 2020
- Address
- 271 A Great Valley Pkwy,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.phanesbiotech.com
- Keywords
- Alzheimer's Disease, Neurodegenerative Disorders, Macular degeneration, Dementia, Neuroregeneration, Amyloid, Tau.
- HQ
- Malvern, Pennsylvania
Phanes Biotech Questions
Phanes Biotech's website is http://www.phanesbiotech.com
Phanes Biotech's LinkedIn profile is https://www.linkedin.com/company/phanes-biotech
Phanes Biotech has
4 employees.
View email and phone details for 4
employees at Phanes Biotech.
Phanes Biotech's industry is
Biotechnology Research
Phanes Biotech's top competitors are
Xencor,
Phanes Therapeutics, Inc.,
Qnu Labs,
White Ink Capital,
Qusecure,
Travere Therapeutics,
Veravas, Inc.,
Nls Pharmaceutics Ag,
Christiaan & Company,
Longboard Pharmaceuticals.
Phanes Biotech's categories are Biotechnology Research
Phanes Biotech's founding year is 2020
